US Institute to build major Campus in Oxford
Dinah Rose
David Agus
David Agus
Rory Maw
Rory Maw

News

US Institute to build major Campus in Oxford

19 Jul, 2022

Published over 3 years ago. See the latest and most current information on News.

The Oxford Science Park (TOSP), a leading European location for science and technology companies has agreed to sell a 150-year lease on a 3.5 acre site in the park to facilitate expansion by the Lawrence J. Ellison Institute for Transformative Medicine which plans to establish a major presence in Oxford.

The site connects directly with the adjacent 5.9-acre Littlemore House site that the Ellison Institute acquired in December 2021.

The Ellison Institute’s Oxford campus will provide a permanent home to research laboratories, a patient clinic, offices and collaborative spaces supporting Ellison Institute projects, including the Global Health Security Consortium’s work on pandemic preparedness.

It will also enable extensive collaboration with organisations and companies located across the park, including expansion of its existing partnership with Oxford Nanopore Technologies.

Rory Maw, CEO of The Oxford Science Park, said, ‘We’re delighted to welcome the Ellison Institute to the Park and look forward to working with the team to help deliver their vision for the new Oxford campus. This commitment will reinforce the ground-breaking research and development already taking place on the Park, delivering benefits and opportunities for our occupiers and the wider Oxford innovation ecosystem.’

Dinah Rose QC, President of Magdalen College, said, “Following closely on from our strategic partnership with GIC, the Singapore sovereign wealth fund, this is an exciting next step in the evolution of the Park. We look forward to developing a close long-term relationship with the Ellison Institute and to enhancing further Oxford’s enormous contribution to addressing global health challenges.’

 ‘We look forward to continuing the development of our Oxford presence and partnerships,’ said Dr David Agus, founding director and CEO of the Ellison Institute. ‘These acquisitions give us greater capacity to undertake critical biomedical research as well as the educational initiatives of the Institute in collaboration with Oxford University.’

More information online

Latest News

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Advanced multi-channel gas mixing for reliable AMS verification
Explore more Arrow
Pollution Solutions Online
DNV introduces new framework for measuring onboard carbon capture performance
Explore more Arrow
Petro Online
New test method ASTM D8606 has been officially released
Explore more Arrow
Chromatography Today
Affordable liquid chromatography solvent delivery pump
Explore more Arrow